Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
Kymentie Ferdinande, PhD Researcher UNIPD at University of Padova, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“We are pleased to share our Letter to the Editor in Journal of Thrombosis and Haemostasis (JTH) commenting on the recent work by Cindy Pereira Portela, Lorenzo Alberio and colleagues on the effect of direct oral anticoagulants in cirrhosis.
In this letter, we present complementary in vitro data on rivaroxaban in cirrhosis, in line with those of Portela et al.. Together, these observations support the need for more individualized anticoagulation strategies in cirrhosis, an area that warrants further investigation.
Many thanks to the authors for their interesting reply!”
Title: “Effect of direct oral anticoagulants in cirrhosis: an in vitro study”: comment
Authors: Kymentie Ferdinande, Jill Vercruyssen, Jochen Decaestecker, Charlotte De Vloo, Inge Van Haute, Helena Degroote, Sarah Raevens, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Katrien M. J. Devreese
Read the Full Article on Journal of Thrombosis and Hemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms